Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 82043459

  Document Type - Tender Notices

Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for finished medicinal products with the active ingredient Rivaroxaban (ATC: B01AF01 - with a potenc y of 2.5 mg per divided oral dosage form) within the framework of a so-called "open-house" model". Subject to uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement in accordance with Section 130a Paragraph 8 SGB V for the above-mentioned active ingredients or medicines. Inter

Gt Ref Id - 82043459

Deadline - Apr 30, 2026